The US Government keeps an online database, at clinicaltrials.gov, of clinical research studies for Mesothelioma cancer, but doesn't review or approve the safety and science of these trials. The website is maintained by the National Library of Medicine (NLM). The links below go to the clinical trial information on clinicaltrials.gov. Talk with your health care professional about possible risks and benefits before joining any studies.
Sun, 27 Apr 2025 00:00:00 EDT
Conditions: Suspected Malignant Lung Neoplasm; Pleural Effusion; Pleural Effusion, Malignant; Mesothelioma, Malignant
Interventions: Procedure: Local Anesthesia Thoracoscopy; Device: Pleuroscopy with Rigid Thoracoscope and Forceps biopsies
Sponsors: National and Kapodistrian University of Athens; Sotiria Thoracic Diseases Hospital of Athens
Recruiting
Wed, 30 Apr 2025 00:00:00 EDT
Conditions: Pleural Mesotheliomas
Interventions: Drug: Ivonescimab
Sponsors: Intergroupe Francophone de Cancerologie Thoracique; Summit Therapeutics
Not yet recruiting
Wed, 30 Apr 2025 00:00:00 EDT
Conditions: Mesothelioma; Malignant Mesothelioma (MM); Early-stage Mesothelioma; Subclinical Mesothelioma; BRCA1-Associated Protein-1 (BAP1) Mutations; Early-stage BAP1-associated Malignancies
Interventions: Drug: alrizomadlin
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
Sun, 20 Apr 2025 00:00:00 EDT
Conditions: Carcinoma, Non-Small-Cell Lung; Ovarian Neoplasms; Pancreatic Adenocarcinoma; Colorectal Neoplasms; Mesothelioma; Other Solid Tumors; Endometrial
Interventions: Drug: PF-08052666
Sponsors: Seagen, a wholly owned subsidiary of Pfizer
Recruiting
Thu, 24 Apr 2025 00:00:00 EDT
Conditions: Unresectable Pleural Mesothelioma
Interventions: Drug: Volrustomig; Drug: Pemetrexed; Drug: Carboplatin; Drug: Cisplatin; Drug: Nivolumab; Drug: Ipilimumab
Sponsors: AstraZeneca
Recruiting
Sun, 20 Apr 2025 00:00:00 EDT
Conditions: Advanced Renal Cell Carcinoma; Advanced Mesothelioma; Advanced Osteosarcoma
Interventions: Drug: CAR.70/IL15-transduced CB-derived NK cells; Drug: Fludarabine phosphate; Drug: Cyclophosphamide
Sponsors: M.D. Anderson Cancer Center
Recruiting
Sun, 20 Apr 2025 00:00:00 EDT
Conditions: High Grade Epithelial Ovarian Cancer; High Grade Serous Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer; Endometrial Cancer; Non-small Cell Lung Cancer; Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC); Mesothelioma; Breast Adenocarcinoma; Triple Negative Breast Cancer; Hormone Receptor-positive/Her2 Negative Breast Cancer; Platinum-resistant Ovarian Cancer (PROC); Platinum Sensitive Ovarian Cancer (PSOC); Primary Refractory Ovarian Cancer; Uterine Cancer
Interventions: Drug: Rina-S; Drug: Carboplatin; Drug: Bevacizumab; Drug: Pembrolizumab
Sponsors: Genmab
Recruiting
Sun, 20 Apr 2025 00:00:00 EDT
Conditions: Microsatellite High Cancers; Peritoneal Mesothelioma; Extrapulmonary High Grade; Neuroendocrine Carcinomas; Cervical Carcinoma; Hodgkin's Lymphoma; Pleural Mesothelioma; Small Cell Lung Cancer
Interventions: Drug: XmAb20717
Sponsors: M.D. Anderson Cancer Center
Suspended
Fri, 25 Apr 2025 00:00:00 EDT
Conditions: Mesotheliomas Pleural
Interventions: Biological: Mesopher
Sponsors: Erasmus Medical Center
Recruiting
Thu, 17 Apr 2025 00:00:00 EDT
Conditions: Peritoneal Malignant Mesothelioma
Interventions: Biological: Atezolizumab; Biological: Bevacizumab; Procedure: Biospecimen Collection; Drug: Carboplatin; Procedure: Computed Tomography; Procedure: Cytoreductive Surgery; Drug: Hyperthermic Intraperitoneal Chemotherapy; Drug: Pemetrexed; Procedure: Positron Emission Tomography
Sponsors: National Cancer Institute (NCI)
Recruiting
Menu